For decades neuro-oncology meetings have benefited from controversial, sometimes heated and emotional debates on the role of surgery for what has traditionally been falsely designated 'low grade' glioma; falsely since 'low grade' glioma evokes false expectations for often young patients and their caregivers confronted with a disease with a median survival around 7–8 years.
http://ift.tt/2f80pBH
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου